AAP IMPLANTATE (AAQ1.DE) Stock Price, Forecast & Analysis
Europe - FRA:AAQ1 - DE000A3H2101 - Common Stock
AAQ1.DE Key Statistics, Chart & Performance
The current stock price of AAQ1.DE is 1.45 EUR. In the past month the price decreased by -8.81%. In the past year, price decreased by -17.14%.
AAQ1.DE Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| ABL.DE | ABBOTT LABORATORIES | 24.85 | 186.86B | ||
| IUI1.DE | INTUITIVE SURGICAL INC | 62.06 | 165.74B | ||
| 1ISRG.MI | INTUITIVE SURGICAL INC | 61.93 | 165.38B | ||
| BSX.DE | BOSTON SCIENTIFIC CORP | 33.88 | 128.02B | ||
| 2M6.DE | MEDTRONIC PLC | 16.45 | 101.09B | ||
| SHL.DE | SIEMENS HEALTHINEERS AG | 20.41 | 54.79B | ||
| 1BDX.MI | BECTON DICKINSON AND CO | 12.82 | 44.91B | ||
| BOX.DE | BECTON DICKINSON AND CO | 12.56 | 44.46B | ||
| EWL.DE | EDWARDS LIFESCIENCES CORP | 32.66 | 42.57B | ||
| 1DXCM.MI | DEXCOM INC | 36.68 | 23.16B | ||
| PHI1.DE | KONINKLIJKE PHILIPS NV | 16.5 | 22.88B | ||
| PHIA.AS | KONINKLIJKE PHILIPS NV | 16.49 | 22.86B |
Related stock screener links
About AAQ1.DE
Company Profile
aap Implantate AG is a medical device company, which engages in the development, manufacture, and market of trauma products for orthopedics. The company is headquartered in Berlin, Berlin and currently employs 90 full-time employees. The firm focuses on trauma and biomaterials products for orthopedics. The Biomaterials portfolio comprises bone substitutes for the filling of aseptic bone defects, bone cements and accessories for the application in arthroplasty, bone cements and accessories for the application in vertebroplasty and kyphoplasty. The trauma portfolio includes a wide range of cannulated screws, standard plates and screws for miniature, small and large bone fragments, among others . The company also develops LOQTEQ, a technology that allows for fracture compression with subsequent locking fixation in one surgical step. The firm operates a network of distributors in more than 60 countries, and cooperates directly with physicians and hospital customers.
Company Info
AAP IMPLANTATE
Lorenzweg 5
Berlin BERLIN DE
Employees: 90
Phone: 4930750190
AAP IMPLANTATE / AAQ1.DE FAQ
What does AAQ1 do?
aap Implantate AG is a medical device company, which engages in the development, manufacture, and market of trauma products for orthopedics. The company is headquartered in Berlin, Berlin and currently employs 90 full-time employees. The firm focuses on trauma and biomaterials products for orthopedics. The Biomaterials portfolio comprises bone substitutes for the filling of aseptic bone defects, bone cements and accessories for the application in arthroplasty, bone cements and accessories for the application in vertebroplasty and kyphoplasty. The trauma portfolio includes a wide range of cannulated screws, standard plates and screws for miniature, small and large bone fragments, among others . The company also develops LOQTEQ, a technology that allows for fracture compression with subsequent locking fixation in one surgical step. The firm operates a network of distributors in more than 60 countries, and cooperates directly with physicians and hospital customers.
What is the current price of AAQ1 stock?
The current stock price of AAQ1.DE is 1.45 EUR. The price decreased by -2.68% in the last trading session.
Does AAP IMPLANTATE pay dividends?
AAQ1.DE does not pay a dividend.
What is the ChartMill rating of AAP IMPLANTATE stock?
AAQ1.DE has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 2 out of 10.
What is the GICS sector and industry of AAQ1 stock?
AAP IMPLANTATE (AAQ1.DE) operates in the Health Care sector and the Health Care Equipment & Supplies industry.
What is the Price/Earnings (PE) ratio of AAP IMPLANTATE (AAQ1.DE)?
AAP IMPLANTATE (AAQ1.DE) does not have a PE ratio as the earnings reported over the last twelve months were negative (-0.28).
AAQ1.DE Technical Analysis
AAQ1.DE Fundamental Analysis
ChartMill assigns a fundamental rating of 2 / 10 to AAQ1.DE. AAQ1.DE scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages.
AAQ1.DE Financial Highlights
Over the last trailing twelve months AAQ1.DE reported a non-GAAP Earnings per Share(EPS) of -0.28. The EPS increased by 68.18% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -25.96% | ||
| ROE | -38.7% | ||
| Debt/Equity | 0.03 |
AAQ1.DE Forecast & Estimates
For the next year, analysts expect an EPS growth of 65% and a revenue growth 15.38% for AAQ1.DE